Protea, Gelcompany to Collaborate on Protein Analysis Products | GenomeWeb

NEW YORK (GenomeWeb News) – Protea Biosciences and Gelcompany, a wholly owned subsidiary of Australian firm Fluorotechnics, today said that they will collaborate on developing new technology for improved protein analysis.

Under the agreement, Protea has the right to distribute certain Gelcompany products in the North American life sciences market. The companies also said that they intend to collaborate on the co-development of new protein separation products for the global life sciences market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.